{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:13:43Z","timestamp":1785780823790,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T00:00:00Z","timestamp":1476403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11606-016-3844-6","type":"journal-article","created":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T19:20:26Z","timestamp":1476472826000},"page":"159-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness Analysis"],"prefix":"10.1007","volume":"32","author":[{"given":"Phuc","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Rothberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,14]]},"reference":[{"issue":"11","key":"3844_CR1","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","volume":"82","author":"BP Yawn","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341\u20139.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"3844_CR2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6), e004833.","journal-title":"BMJ Open"},{"issue":"8","key":"3844_CR3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archinte.1997.00440290095010","volume":"157","author":"JL Jackson","year":"1997","unstructured":"Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis. Arch Intern Med. 1997;157(8):909\u201312.","journal-title":"Arch Intern Med"},{"issue":"6","key":"3844_CR4","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","volume":"60","author":"VA Morrison","year":"2015","unstructured":"Morrison VA, Johnson GR, Schmader KE, Levin MJ, Zhang JH, Looney DJ, et al. Long-term persistence of zoster vaccine efficacy. Clin Infect Dis. 2015;60(6):900\u20139.","journal-title":"Clin Infect Dis"},{"issue":"22","key":"3844_CR5","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271\u201384.","journal-title":"N Engl J Med"},{"issue":"7","key":"3844_CR6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","volume":"54","author":"KE Schmader","year":"2012","unstructured":"Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years. Clin Infect Dis. 2012;54(7):922\u20138.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"3844_CR7","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/cis638","volume":"55","author":"KE Schmader","year":"2012","unstructured":"Schmader KE, Oxman MN, Levin MJ, Johnson G, Zhang JH, Betts R, et al. Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis. 2012;55(10):1320\u20138.","journal-title":"Clin Infect Dis"},{"issue":"33","key":"3844_CR8","first-page":"729","volume":"63","author":"CM Hales","year":"2014","unstructured":"Hales CM, Harpaz R, Ortega-Sanchez I, Bialek SR. Update on recommendations for use of herpes zoster vaccine. MMWR Morb Mortal Wkly Rep. 2014;63(33):729\u201331.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"3844_CR9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7326\/M15-0093","volume":"163","author":"P Le","year":"2015","unstructured":"Le P, Rothberg MB. Cost-effectiveness of herpes zoster vaccine for persons aged 50 years. Ann Intern Med. 2015;163(7):489\u201397.","journal-title":"Ann Intern Med"},{"key":"3844_CR10","unstructured":"Levin MJ, Schmader KE, Pang L, Williams-Diaz A, Zerbe G, Canniff J, et al. Administration of a second dose of herpes zoster vaccine ten years after a first dose. J Infect Dis. 2015."},{"issue":"10","key":"3844_CR11","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1086\/514342","volume":"44","author":"MB Rothberg","year":"2007","unstructured":"Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis. 2007;44(10):1280\u20138.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3844_CR12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","volume":"52","author":"J Leung","year":"2011","unstructured":"Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F. Herpes zoster incidence among insured persons in the United States, 1993\u20132006: evaluation of impact of varicella vaccination. Clin Infect Dis. 2011;52(3):332\u201340.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3844_CR13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","volume":"20","author":"RP Insinga","year":"2005","unstructured":"Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20(8):748\u201353.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"3844_CR14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.pain.2011.10.026","volume":"153","author":"D Bouhassira","year":"2012","unstructured":"Bouhassira D, Chassany O, Gaillat J, Hanslik T, Launay O, Mann C, et al. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice. Pain. 2012;153(2):342\u20139.","journal-title":"Pain"},{"issue":"7264","key":"3844_CR15","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.321.7264.794","volume":"321","author":"S Helgason","year":"2000","unstructured":"Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ. 2000;321(7264):794\u20136.","journal-title":"BMJ"},{"issue":"6","key":"3844_CR16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/591132","volume":"47","author":"LA Jackson","year":"2008","unstructured":"Jackson LA, Reynolds MA, Harpaz R. Hospitalizations to treat herpes zoster in older adults: causes and validated rates. Clin Infect Dis. 2008;47(6):754\u20139.","journal-title":"Clin Infect Dis"},{"key":"3844_CR17","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File 1999\u20132012 on CDC WONDER Online Database, released October 2014. Data are from the Compressed Mortality File 1999\u20132012 Series 20 No. 2R, 2014, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Available at: http:\/\/wonder.cdc.gov\/cmf-icd10.html . Accessed 19 July 2016."},{"key":"3844_CR18","unstructured":"Agency for Healthcare Research and Quality. Healthcare cost and utilization project-HCUP. Available at http:\/\/hcupnet.ahrq.gov\/HCUPnet.jsp Accessed 19 July 2016."},{"issue":"4","key":"3844_CR19","first-page":"95","volume":"64","author":"WW Williams","year":"2015","unstructured":"Williams WW, Lu PJ, O\u2019Halloran A, Bridges CB, Kim DK, Pilishvili T, et al. Vaccination coverage among adults, excluding influenza vaccination - United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(4):95\u2013102.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3844_CR20","unstructured":"Zoster vaccine live (Oka\/Merck) Zostavax. FDA clinical briefing document for Merck and Co., 2005 [Internet]. Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/05\/briefing\/5-4198b2_1.pdf . Accessed on 19 July 2016."},{"issue":"23\u201324","key":"3844_CR21","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","volume":"19","author":"WJ Edmunds","year":"2001","unstructured":"Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine. 2001;19(23\u201324):3076\u201390.","journal-title":"Vaccine"},{"issue":"5","key":"3844_CR22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-145-5-200609050-00004","volume":"145","author":"J Hornberger","year":"2006","unstructured":"Hornberger J, Robertus K. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Ann Intern Med. 2006;145(5):317\u201325.","journal-title":"Ann Intern Med"},{"issue":"6","key":"3844_CR23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","volume":"5","author":"PM Coplan","year":"2004","unstructured":"Coplan PM, Schmader K, Nikas A, Chan IS, Choo P, Levin MJ, et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain. 2004;5(6):344\u201356.","journal-title":"J Pain"},{"key":"3844_CR24","unstructured":"Centers for Disease Control and Prevention. Adult vaccine price list. Available at: http:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/ . Accessed 29 July 2016."},{"key":"3844_CR25","unstructured":"Centers for Medicare and Medicaid services. Physician Fee Schedule. Available at: http:\/\/www.cms.gov\/apps\/physician-fee-schedule\/search\/search-results.aspx?Y=0&T=0&HT=0&CT=3&H1=90471&M=5 . Accessed 19 July 2016."},{"issue":"4","key":"3844_CR26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/027298902400448867","volume":"22","author":"AH Briggs","year":"2002","unstructured":"Briggs AH, Goeree R, Blackhouse G, O\u2019Brien BJ. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making. 2002;22(4):290\u2013308.","journal-title":"Med Decis Making"},{"key":"3844_CR27","unstructured":"WHO-CHOICE. Choosing interventions that are cost-effective. [Internet]. Available at: http:\/\/www.who.int\/choice\/en . Accessed 19 July 2016."},{"key":"3844_CR28","unstructured":"Bureau of Labor Statistic. Medical care component of the Consumer Price Index-All urban consumers. Available at: http:\/\/data.bls.gov\/cgi-bin\/surveymost . Accessed 19 July 2016."},{"issue":"11","key":"3844_CR29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-159-11-201312030-00006","volume":"159","author":"CM Hales","year":"2013","unstructured":"Hales CM, Harpaz R, Joesoef MR, Bialek SR. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med. 2013;159(11):739\u201345.","journal-title":"Ann Intern Med"},{"issue":"RR-4","key":"3844_CR30","first-page":"1","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin M, Guris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1\u201340.","journal-title":"MMWR Recomm Rep"},{"issue":"22","key":"3844_CR31","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087\u201396.","journal-title":"N Engl J Med"},{"issue":"7","key":"3844_CR32","first-page":"1","volume":"63","author":"E Arias","year":"2014","unstructured":"Arias E. United States life tables, 2010. Natl Vital Stat Rep. 2014;63(7):1\u201363.","journal-title":"Natl Vital Stat Rep"},{"key":"3844_CR33","unstructured":"U.S. Census Bureau, Population Division. Annual Estimates of the Resident Population by Single Year of Age and Sex for the United States: April 1, 2010 to July 1, 2013. Release Date: June 2014. Available at: http:\/\/factfinder.census.gov\/faces\/tableservices\/jsf\/pages\/productview.xhtml?src=bkmk . Accessed 19 July 2016."},{"issue":"Suppl 2","key":"3844_CR34","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.2105\/AJPH.2008.151332","volume":"99","author":"JC Nelson","year":"2009","unstructured":"Nelson JC, Bittner RC, Bounds L, Zhao S, Baggs J, Donahue JG, et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study. Am J Public Health. 2009;99(Suppl 2):S389\u201397.","journal-title":"Am J Public Health"},{"issue":"6","key":"3844_CR35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.amepre.2008.01.033","volume":"34","author":"ET Luman","year":"2008","unstructured":"Luman ET, Shaw KM, Stokley SK. Compliance with vaccination recommendations for U.S. children. Am J Prev Med. 2008;34(6):463\u201370.","journal-title":"Am J Prev Med"},{"issue":"1","key":"3844_CR36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1542\/peds.2010-0812","volume":"127","author":"LE Widdice","year":"2011","unstructured":"Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 2011;127(1):77\u201384.","journal-title":"Pediatrics"},{"issue":"4","key":"3844_CR37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/0272989X06290497","volume":"26","author":"J Hanmer","year":"2006","unstructured":"Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG. Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Making. 2006;26(4):391\u2013400.","journal-title":"Med Decis Making"},{"key":"3844_CR38","unstructured":"Labor Force Statistics from the Current Population Survey-Employment status of the civilian noninstitutional population by age, sex, and race [Internet]. Available at: http:\/\/www.bls.gov\/web\/empsit\/cpseea13.htm . Accessed 29 July 2016."},{"issue":"49","key":"3844_CR39","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1016\/j.vaccine.2007.09.066","volume":"25","author":"JM Pellissier","year":"2007","unstructured":"Pellissier JM, Brisson M, Levin MJ. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine. 2007;25(49):8326\u201337.","journal-title":"Vaccine"},{"key":"3844_CR40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/1472-6963-13-359","volume":"13","author":"B Ultsch","year":"2013","unstructured":"Ultsch B, Weidemann F, Reinhold T, Siedler A, Krause G, Wichmann O. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC Health Serv Res. 2013;13:359.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"3844_CR41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.vaccine.2011.10.036","volume":"30","author":"J Bilcke","year":"2012","unstructured":"Bilcke J, Marais C, Ogunjimi B, Willem L, Hens N, Beutels P. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium. Vaccine. 2012;30(3):675\u201384.","journal-title":"Vaccine"},{"key":"3844_CR42","volume-title":"Decision and cost-effectiveness analyses of herpes zoster vaccination in adults 50 years of age and older [Presentation]","author":"IR Ortega-Sanchez","year":"2013","unstructured":"Ortega-Sanchez IR. Decision and cost-effectiveness analyses of herpes zoster vaccination in adults 50 years of age and older [Presentation]. Atlanta, GA: US Department of Health and Human Services, CDC; 2013."},{"issue":"9","key":"3844_CR43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","volume":"152","author":"LP Hurley","year":"2010","unstructured":"Hurley LP, Lindley MC, Harpaz R, Stokley S, Daley MF, Crane LA, et al. Barriers to the use of herpes zoster vaccine. Ann Intern Med. 2010;152(9):555\u201360.","journal-title":"Ann Intern Med"},{"issue":"6","key":"3844_CR44","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.vaccine.2008.11.077","volume":"27","author":"PJ Lu","year":"2009","unstructured":"Lu PJ, Euler GL, Jumaan AO, Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine. 2009;27(6):882\u20137.","journal-title":"Vaccine"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-016-3844-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-016-3844-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-016-3844-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:11:10Z","timestamp":1498353070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-016-3844-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,14]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3844"],"URL":"https:\/\/doi.org\/10.1007\/s11606-016-3844-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,14]]}}}